Claudio Luchini
@CLuchini10
Followers
308
Following
2K
Media
23
Statuses
303
Joined January 2021
With Dr. Barbara Centeno representing @pbpath at the 14th Asia Pacific International Academy of Pathology Congress (AP-IAP 2025) in Bangkok. Great time together in this important event in Thailand.
0
0
8
Do you know how to FISH? I am delighted to share our 20+ years of experience with FISH, just published in @Human_Pathology (PMID: 40782985) - Everything You Need to Know About FISH! This comprehensive review covers the full spectrum of fluorescence in situ hybridization (FISH)
6
70
240
David Klimstra, MD, right, was introduced as the inaugural Louis JM Zinterhofer, MD Professor of Pathology on Sept. 18, thanks to the generosity of Eric Zinterhofer, left. At center is Dr. Zinterhofer, a Pathology resident @YaleMed from 1967 to 1971. https://t.co/w3Xy7ZhR7g
0
2
15
New PBPS Case of the Quarter is live! PBPS members—please check out the latest case and join the discussion. Log in to view and comment: https://t.co/wxno1VNdk5
1
10
14
Join us in Philadelphia for the 2nd Annual Advancing Precision Medicine Conference - Worldwide Innovation Networking (WIN) Symposium, taking place October 3–4, 2025 at the Pennsylvania Convention Center! The Organizing Committee has curated an exceptional program under the theme
1
9
19
Really a special moment at the end of the European Congress of Pathology, the Juan Rosai Lecture by @DrNetto...outstanding presentation pointing the way of pathology towards the future
2
4
30
Kick-off of the slide seminar on “Cystic lesions of the pancreatobiliary tract" starting now #ecp2025 @ESP_Pathology @pbpath chaired by @Huaminwang6 @IEspositoPATH
0
2
16
Join us for an exciting slide seminar on “Cystic lesions of the pancreatobiliary tract” on Tuesday, Sept 9th at 5.30 PM, Hall A #ecp2025 @ESP_Pathology
1
9
19
Introducing Precision Pathology Podcast! @ESP_Pathology @TheUSCAP @ASCO @Nature @CellCellPress @ScienceMagazine @PennMedicine @PennPathLabMed @Pathologists
podcasts.apple.com
Podcast Episode · Precision Pathology Podcast (P³) · 08/27/2025 · 1 sec
2
12
49
Truly honored to be part of this work with such an outstanding team. This is an inspiring international collaboration.
Online Now: Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct patterns and potential markers of progression https://t.co/eCB6yYNTqT
0
1
3
New resource paper @Cancer_Cell paper by @RalphHruban et al @hopkinskimmel Multi-omic profiling (MS-based Proteins & Glycoproteins) of intraductal papillary neoplasms of the pancreas (IPMNs) reveals distinct patterns and potential markers of progression https://t.co/EaXVJ2aJEL
1
9
32
Our multi-institutional collaborative study of the proteins and glycoproteins expressed in intraductal papillary mutinous neoplasms (IPMNs) of the pancreas was just published in Cancer Cell. https://t.co/zzop5P3l09
1
6
17
New PBPS Case of the Quarter is live! PBPS members—check out the latest case and join the discussion. Log in to view and comment: (https://t.co/09vbKXq2Bc)@MichelleReidMD @OlcaBasturk @AgostiniVulajDO @Mvgs1706 @RaulSGonzalezMD @Huaminwang6 @CLuchini10 @navale_pooja @VidyaArole
pbpath.org
Case Title: A solid hypercellular neoplasm of the pancreas Clinical History A 73-year-old woman presented to surgical oncology for evaluation of a
2
8
16
The PBPS Journal Watch (June – August 2025) is out! Please log in to download, read, and track newly released articles in pancreatobiliary pathology: https://t.co/PeybVuhkXZ
@MichelleReidMD @OlcaBasturk @AgostiniVulajDO @Mvgs1706 @RaulSGonzalezMD @Huaminwang6 @CLuchini10
pbpath.org
Welcome to the PBPath Journal Watch! This bi-monthly journal watch features exciting recently published pancreas and biliary pathology articles that will provide up to date medical knowledge in our...
1
7
14
Multiple studies have consistently shown prognostic impact of KRAS allelic variants in #PancreaticCancer WT > R > D/V > Q61 Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer https://t.co/iKbiFRw7dL By @MPishvaian @DrHendifar
ascopubs.org
PURPOSETumor molecular profiling is recommended in pancreatic ductal adenocarcinoma (PDAC). However, the predictive and prognostic value of KRAS variants on clinical outcomes including response to...
0
10
38
Virchows Archiv discusses the role of claudin-18 as a predictive biomarker in gastric and gastroesophageal junction adenocarcinomas, highlighting its potential in pancreatic ductal adenocarcinoma cases. https://t.co/7WYNARXWsL
link.springer.com
Virchows Archiv - The evaluation of claudin-18 (CLDN18) by immunohistochemistry (IHC) has already entered routine diagnostic activity as a predictive biomarker for patients with gastric and...
0
5
19
In @CCR_AACR the genomic landscape of germline ATM associated #PancreaticCancer ✅ 25 PDAC tumors profiled ➡️ 87% biallelic ATM loss 📉 TP53 <10% vs CDKN2A 60% 🎯 ADEX subtype → >5y OS 🤖 28-gene OS signature validated #pancsm 💜 @OncoAlert 🚨 https://t.co/3tE4lK3SL4
1
5
22
Our new study on fatty pancreas brings a multi-disciplinary perspective on this emerging topic. Fatty pancreas disease: an integrated study on frozen tissues shows distinct compartments of inter/intra-lobular, intra-acinar, and intra-islet fat deposition
0
4
9